Compare Nuvalent Inc (NUVL) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Plby Group Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Plby Group Inc trades at $1.21 (market cap $139.87M). The key difference: Nuvalent Inc is far larger — about 70.1× Plby Group Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Plby Group Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | PLBY | |
|---|---|---|
Market Cap | $9.81B | $139.87M |
Sector | Technology | Consumer Cyclical |
52-Week High | $123.96 | $2.71 |
52-Week Low | $72.16 | $1.11 |
Enterprise Value | $8.52B | $287.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
